158 related articles for article (PubMed ID: 38098005)
21. The m
Zhang Y; Liu X; Wang Y; Lai S; Wang Z; Yang Y; Liu W; Wang H; Tang B
Mol Cancer; 2022 Sep; 21(1):174. PubMed ID: 36056355
[TBL] [Abstract][Full Text] [Related]
22. Fzd7/Wnt7b signaling contributes to stemness and chemoresistance in pancreatic cancer.
Zhang Z; Xu Y; Zhao C
Cancer Med; 2021 May; 10(10):3332-3345. PubMed ID: 33934523
[TBL] [Abstract][Full Text] [Related]
23. Maintenance of cancer stemness by miR-196b-5p contributes to chemoresistance of colorectal cancer cells via activating STAT3 signaling pathway.
Ren D; Lin B; Zhang X; Peng Y; Ye Z; Ma Y; Liang Y; Cao L; Li X; Li R; Sun L; Liu Q; Wu J; Zhou K; Zeng J
Oncotarget; 2017 Jul; 8(30):49807-49823. PubMed ID: 28591704
[TBL] [Abstract][Full Text] [Related]
24. Understanding the molecular mechanisms that regulate pancreatic cancer stem cell formation, stemness and chemoresistance: A brief overview.
Nagaraju GP; Farran B; Luong T; El-Rayes BF
Semin Cancer Biol; 2023 Jan; 88():67-80. PubMed ID: 36535506
[TBL] [Abstract][Full Text] [Related]
25. The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer.
Pan MR; Hsu MC; Luo CW; Chen LT; Shan YS; Hung WC
Oncotarget; 2016 Sep; 7(38):61136-61151. PubMed ID: 27531902
[TBL] [Abstract][Full Text] [Related]
26. LINC00680 enhances hepatocellular carcinoma stemness behavior and chemoresistance by sponging miR-568 to upregulate AKT3.
Shu G; Su H; Wang Z; Lai S; Wang Y; Liu X; Dai L; Bi Y; Chen W; Huang W; Zhou Z; He S; Dai H; Tang B
J Exp Clin Cancer Res; 2021 Jan; 40(1):45. PubMed ID: 33499874
[TBL] [Abstract][Full Text] [Related]
27. Pancreatic cancer stem cells: new insight into a stubborn disease.
Zhan HX; Xu JW; Wu D; Zhang TP; Hu SY
Cancer Lett; 2015 Feb; 357(2):429-37. PubMed ID: 25499079
[TBL] [Abstract][Full Text] [Related]
28. Expressional changes in stemness markers post electrochemotherapy in pancreatic cancer cells.
Ali MS; Gill KS; Saglio G; Cilloni D; Soden DM; Forde PF
Bioelectrochemistry; 2018 Aug; 122():84-92. PubMed ID: 29574322
[TBL] [Abstract][Full Text] [Related]
29. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
Ma X; Wang B; Wang X; Luo Y; Fan W
PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
[TBL] [Abstract][Full Text] [Related]
30. The therapeutic targeting of the FGFR1/Src/NF-κB signaling axis inhibits pancreatic ductal adenocarcinoma stemness and oncogenicity.
Lai SW; Bamodu OA; Tsai WC; Chang YM; Lee WH; Yeh CT; Chao TY
Clin Exp Metastasis; 2018 Oct; 35(7):663-677. PubMed ID: 29987671
[TBL] [Abstract][Full Text] [Related]
31. Pharmacological targeting PTK6 inhibits the JAK2/STAT3 sustained stemness and reverses chemoresistance of colorectal cancer.
Liu C; Pan Z; Chen Q; Chen Z; Liu W; Wu L; Jiang M; Lin W; Zhang Y; Lin W; Zhou R; Zhao L
J Exp Clin Cancer Res; 2021 Sep; 40(1):297. PubMed ID: 34551797
[TBL] [Abstract][Full Text] [Related]
32. MicroRNA-10a promotes epithelial-to-mesenchymal transition and stemness maintenance of pancreatic cancer stem cells via upregulating the Hippo signaling pathway through WWC2 inhibition.
Wang C; Yin W; Liu H
J Cell Biochem; 2020 Nov; 121(11):4505-4521. PubMed ID: 32542845
[TBL] [Abstract][Full Text] [Related]
33. MicroRNA-485-5p targets keratin 17 to regulate oral cancer stemness and chemoresistance via the integrin/FAK/Src/ERK/β-catenin pathway.
Jang TH; Huang WC; Tung SL; Lin SC; Chen PM; Cho CY; Yang YY; Yen TC; Lo GH; Chuang SE; Wang LH
J Biomed Sci; 2022 Jun; 29(1):42. PubMed ID: 35706019
[TBL] [Abstract][Full Text] [Related]
34. Overexpression of interleukin-20 receptor subunit beta (IL20RB) correlates with cell proliferation, invasion and migration enhancement and poor prognosis in papillary renal cell carcinoma.
Cui XF; Cui XG; Leng N
J Toxicol Pathol; 2019 Oct; 32(4):245-251. PubMed ID: 31719751
[TBL] [Abstract][Full Text] [Related]
35. Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1.
Zhou C; Qian W; Ma J; Cheng L; Jiang Z; Yan B; Li J; Duan W; Sun L; Cao J; Wang F; Wu E; Wu Z; Ma Q; Li X
Cell Prolif; 2019 Jan; 52(1):e12514. PubMed ID: 30341797
[TBL] [Abstract][Full Text] [Related]
36. Sex Determining Region Y Box 9 Induces Chemoresistance in Pancreatic Cancer Cells by Induction of Putative Cancer Stem Cell Characteristics and Its High Expression Predicts Poor Prognosis.
Higashihara T; Yoshitomi H; Nakata Y; Kagawa S; Takano S; Shimizu H; Kato A; Furukawa K; Ohtsuka M; Miyazaki M
Pancreas; 2017; 46(10):1296-1304. PubMed ID: 28984791
[TBL] [Abstract][Full Text] [Related]
37. Metformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133+ Cell Populations and Suppressing ERK/P70S6K Signaling.
Chai X; Chu H; Yang X; Meng Y; Shi P; Gou S
Sci Rep; 2015 Sep; 5():14404. PubMed ID: 26391180
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of hedgehog signaling depresses self-renewal of pancreatic cancer stem cells and reverses chemoresistance.
Huang FT; Zhuan-Sun YX; Zhuang YY; Wei SL; Tang J; Chen WB; Zhang SN
Int J Oncol; 2012 Nov; 41(5):1707-14. PubMed ID: 22923052
[TBL] [Abstract][Full Text] [Related]
39. EZH2 activates CHK1 signaling to promote ovarian cancer chemoresistance by maintaining the properties of cancer stem cells.
Wen Y; Hou Y; Yi X; Sun S; Guo J; He X; Li T; Cai J; Wang Z
Theranostics; 2021; 11(4):1795-1813. PubMed ID: 33408782
[No Abstract] [Full Text] [Related]
40. Pancreatic cancer stem cells: association with cell surface markers, prognosis, resistance, metastasis and treatment.
Fitzgerald TL; McCubrey JA
Adv Biol Regul; 2014 Sep; 56():45-50. PubMed ID: 24925031
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
